Pendulum: The Pioneers of Live Akkermansia
Clinically-studied, keystone strains designed to transform health through the gut microbiome.*

Reimagine the health of your patients by targeting the gut microbiome
Using cutting-edge technology and microbiome science, Pendulum was the first company in the US to market live Akkermansia muciniphila. Akkermansia supports the synthesis of health-promoting postbioitics and strengthens gut barrier integrity.*
Pendulum’s Akkermansia-containing formulations have been clinically studied and published in the British Medical Journal. Improving gut barrier function and maintaining healthy blood sugar levels with Pendulum’s strains is a foundational way to help your patients find optimal health by harnessing the power of the gut microbiome.*
Pendulum is now the #1 GI Doctor recommended Akkermansia brand product.**


Menopause Daily
Menopause Daily features F. prausnitzii, Akkermansia muciniphila and B. infantis, with ERr 731® and black cohosh. Reduces hot flashes and improves sleep.*‡
Get to know the products
Fullscript and Pendulum provider survey with Akkermansia 500 Pro
Will continue to recommend Akkermansia 500 Pro^
Would recommend Akkermansia 500 Pro to other health care providers^

Glucose control clinical efficacy
Pendulum conducted a double-blind, placebo-controlled nutrition study that demonstrated:
- Pendulum Glucose Control’s safety for its intended use
- Glucose control has a significant statistical and clinical impact on A1c and post-meal blood sugar spikes
- -0.6 A1c reduction
- -32.5% post prandial glucose spike reduction
**Based on sales data, 2022-2025
^Based on a IQVIA survey of gastroenterologists, 2025
‡Based on ERr 731®


